|
Delayed
Bombay S.E.
06:02:29 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 35.10 INR | -4.10% |
|
-1.13% | -16.63% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 91.84 | 79.88 |
| Change | - | -13.02% |
| Enterprise Value (EV) 1 | 61.1 | 64.14 |
| Change | - | 4.98% |
| P/E | 21.2x | 19.1x |
| PBR | 1.04x | 0.86x |
| PEG | -1.1x | -5.48x |
| Capitalization / Revenue | 1.12x | 0.84x |
| EV / Revenue | 0.74x | 0.68x |
| EV / EBITDA | 7.34x | 6.31x |
| EV / EBIT | 16x | 12.6x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 1.896 | 1.83 |
| Distribution rate | - | - |
| Net sales 1 | 82.35 | 94.91 |
| EBITDA 1 | 8.319 | 10.16 |
| EBIT 1 | 3.821 | 5.079 |
| Net income 1 | 3.947 | 4.179 |
| Net Debt 1 | -30.75 | -15.75 |
| Reference price 2 | 40.24 | 35.00 |
| Nbr of stocks (in thousands) | 2,282 | 2,282 |
| Announcement Date | 8/26/25 | 8/22/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 848K | ||
| -237.22x | 15.77x | -282.62x | -.--% | 46.87B | ||
| 23.8x | 2.17x | 12.27x | 0.88% | 26.9B | ||
| 15.28x | 1.22x | 6.95x | 5.73% | 6.64B | ||
| 1081.43x | - | - | - | 5.96B | ||
| 51.82x | 9.56x | 32.91x | 0.97% | 3.39B | ||
| -25.85x | - | - | - | 2.59B | ||
| -58.28x | - | - | -.--% | 2.24B | ||
| 14.85x | 1.5x | 5.88x | 5.12% | 2.09B | ||
| 30.07x | 1.58x | 11.81x | 1.5% | 1.83B | ||
| Average | 99.55x | 5.30x | -35.47x | 2.03% | 9.85B | |
| Weighted average by Cap. | -39.29x | 9.62x | -145.06x | 0.87% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
















